Comprehensive Segmental Revision System

NCT03270982 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2025-12-23

No results posted yet for this study

Summary

Clinical Data evaluation to document the performance and clinical outcomes of the Comprehensive Segmental Revision System.

Conditions

Interventions

DEVICE

Comprehensive SRS Replacement

This system consist of a proximal humeral replacement, distal humeral replacement, or total humeral replacement.

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Emilie Rohmer · Clinical Operations Director Zimmer Biomet EMEA

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2035-12-31
Completion
2035-12-31
FDA Device
Yes

Countries

  • Canada
  • Denmark
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03270982 on ClinicalTrials.gov